Personal tools

Coexpression cluster:C4011: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
{{Coexpression_clusters
{
|coexpression_dpi_cluster_scores_median=-0.00633281832899837

Latest revision as of 12:37, 17 September 2013


Full id: C4011_clear_endometrial_Endothelial_serous_prostate_anaplastic_Renal



Phase1 CAGE Peaks

Hg19::chr1:94703118..94703184,-p1@ARHGAP29
Hg19::chr1:94713235..94713250,-p@chr1:94713235..94713250
-
Hg19::chr1:94713255..94713335,-p@chr1:94713255..94713335
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
cell layer2.93e-33309
epithelium3.22e-32306
anatomical cluster6.84e-24373
anatomical conduit4.56e-23240
epithelial tube5.55e-23117
organism subdivision3.94e-22264
anatomical system7.32e-22624
anatomical group1.75e-21625
multi-cellular organism1.26e-20656
multi-tissue structure1.90e-20342
unilaminar epithelium7.10e-20148
vasculature3.16e-1978
vascular system3.16e-1978
trunk2.43e-18199
mesenchyme3.76e-18160
entire embryonic mesenchyme3.76e-18160
tube3.76e-17192
splanchnic layer of lateral plate mesoderm5.98e-1783
vessel2.65e-1568
epithelial tube open at both ends4.69e-1459
blood vessel4.69e-1459
blood vasculature4.69e-1459
vascular cord4.69e-1459
circulatory system1.66e-13112
trunk mesenchyme1.92e-13122
cardiovascular system1.94e-13109
embryo5.15e-12592
multilaminar epithelium1.95e-1183
simple squamous epithelium2.91e-1122
developing anatomical structure3.39e-11581
epithelial vesicle5.46e-1178
squamous epithelium8.63e-1125
blood vessel endothelium1.39e-1018
endothelium1.39e-1018
cardiovascular system endothelium1.39e-1018
compound organ6.00e-1068
primordium7.01e-10160
organ2.25e-09503
artery2.33e-0942
arterial blood vessel2.33e-0942
arterial system2.33e-0942
somite3.05e-0971
presomitic mesoderm3.05e-0971
presumptive segmental plate3.05e-0971
dermomyotome3.05e-0971
trunk paraxial mesoderm3.05e-0971
dense mesenchyme tissue3.31e-0973
paraxial mesoderm5.45e-0972
presumptive paraxial mesoderm5.45e-0972
renal system1.45e-0848
urinary system structure1.63e-0847
embryonic structure2.92e-08564
organ part2.93e-08218
surface structure5.05e-0899
germ layer1.18e-07560
germ layer / neural crest1.18e-07560
embryonic tissue1.18e-07560
presumptive structure1.18e-07560
germ layer / neural crest derived structure1.18e-07560
epiblast (generic)1.18e-07560
nephron epithelium1.75e-0715
renal tubule1.75e-0715
nephron tubule1.75e-0715
nephron1.75e-0715
uriniferous tubule1.75e-0715
nephrogenic mesenchyme1.75e-0715
skeletal muscle tissue3.69e-0762
striated muscle tissue3.69e-0762
myotome3.69e-0762
systemic artery4.16e-0733
systemic arterial system4.16e-0733
trunk region element4.77e-07101
excretory tube5.28e-0716
kidney epithelium5.28e-0716
organ component layer5.37e-0766
muscle tissue7.02e-0764
musculature7.02e-0764
musculature of body7.02e-0764


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)
MA0003.12.05336
MA0004.10.826076
MA0006.10.639288
MA0007.10.804807
MA0009.11.3275
MA0014.11.24048
MA0017.10.686276
MA0019.10.990656
MA0024.11.21731
MA0025.11.46617
MA0027.12.95767
MA0028.10.658629
MA0029.11.23771
MA0030.11.22561
MA0031.11.15713
MA0038.10.94098
MA0040.11.24388
MA0041.10.847069
MA0042.10.810843
MA0043.11.32783
MA0046.11.31611
MA0048.12.45333
MA0050.10.81185
MA0051.10.936307
MA0052.11.24796
MA0055.11.06172
MA0056.10
MA0057.10.333427
MA0058.10.716037
MA0059.10.714521
MA0060.12.13518
MA0061.10.456531
MA0063.10
MA0066.10.941452
MA0067.11.65513
MA0068.10.405474
MA0069.11.31207
MA0070.11.30033
MA0071.10.897953
MA0072.11.29561
MA0073.15.87909
MA0074.10.935474
MA0076.10.734647
MA0077.11.28751
MA0078.11.04495
MA0081.10.714712
MA0083.11.33535
MA0084.11.84562
MA0087.11.29304
MA0088.10.715722
MA0089.10
MA0090.10.751469
MA0091.10.829044
MA0092.10.785956
MA0093.10.642957
MA0095.10
MA0098.10
MA0100.10.956299
MA0101.10.646932
MA0103.10.628063
MA0105.10.31555
MA0106.12.25834
MA0107.10.556367
MA0108.21.15387
MA0109.10
MA0111.10.767139
MA0113.11.00436
MA0114.10.549955
MA0115.11.57693
MA0116.10.560723
MA0117.11.36676
MA0119.10.695578
MA0122.11.39371
MA0124.11.53432
MA0125.11.44766
MA0130.10
MA0131.11.06461
MA0132.10
MA0133.10
MA0135.11.35921
MA0136.10.948776
MA0139.11.12079
MA0140.10.894983
MA0141.10.712476
MA0142.11.12317
MA0143.11.00455
MA0144.10.531867
MA0145.10.273764
MA0146.11.16674
MA0147.10.565108
MA0148.10.854239
MA0149.10.884158
MA0062.20.449458
MA0035.20.894194
MA0039.22.15877
MA0138.21.04628
MA0002.22.08438
MA0137.20.666381
MA0104.20.491226
MA0047.20.973066
MA0112.20.264678
MA0065.20.277623
MA0150.10.744617
MA0151.10
MA0152.10.902317
MA0153.11.43021
MA0154.11.51687
MA0155.11.31345
MA0156.10.669101
MA0157.11.09377
MA0158.10
MA0159.10.565904
MA0160.10.871361
MA0161.10
MA0162.10.8915
MA0163.10.387745
MA0164.11.01792
MA0080.20.643061
MA0018.20.987913
MA0099.20.902716
MA0079.22.28794
MA0102.21.88331
MA0258.10.519674
MA0259.10.575594
MA0442.10



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF#promotersEnrichmentp-valueq-value
E2F1#186934.907389214879320.008460985347239390.0325808144193029
TCF7L2#6934310.77017656313730.0008003181298398380.00614410652472382



Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.